Fitness & Wearable Tech — 2026-04-13

Wearable Hardware

Garmin CIRQA (Screenless Smart Band)

• Brand: Garmin
• What's new: Garmin has officially filed a trademark for a screenless wearable called CIRQA and patents confirm the device will use electronic sensors to analyze "physiological data, bio-signals, and bodily behavior." Multiple sources this week confirmed it is coming imminently, with leaked proof showing it is a direct play on the WHOOP-style band format — but without a mandatory subscription model.
• Why it matters: The screenless fitness band category has been exploding, with WHOOP clones proliferating across the market. Garmin's entry brings the brand's reputation for data accuracy and GPS precision to a form factor it has never occupied. Crucially, Garmin appears to be positioning CIRQA as a subscription-free alternative — a direct counter to WHOOP's revenue model — which could reshape the recovery and readiness tracking segment.

Samsung Galaxy Watch — Blood Pressure Monitoring in the US

• Brand: Samsung
• What's new: Samsung Galaxy Watch blood pressure monitoring has officially arrived in the United States as of this week. The feature is positioned under the FDA's General Wellness policy for low-risk devices — aligned with guidance the FDA updated in January 2026 for consumer wearables — meaning it does not require a 510(k) clearance.
• Why it matters: Blood pressure monitoring on a consumer wrist wearable has been a highly sought-after feature that Apple Watch has not yet managed to bring to market in the US. Samsung's rollout marks a meaningful step forward for Galaxy Watch users, and could accelerate pressure on Apple to match the capability. The FDA's evolving wellness policy framework is now providing clearer pathways for features like this to reach consumers.

The Rise of Screenless Wearables — Market Trend

• Brand: Industry-wide
• What's new: A TechRadar analysis published this week explores how the "return to analog" aesthetic trend and proliferation of WHOOP-style clones is reshaping consumer attitudes toward smartwatches. The piece argues that smartwatches, like smartphones before them, have become ubiquitous but no longer culturally "cool" — driving a new wave of minimalist, screen-free health trackers.
• Why it matters: This cultural shift has real market implications. Brands like Ultrahuman, Amazfit, and now Garmin are all betting that serious health-focused consumers will trade a display for longer battery life, a lighter form factor, and a lower price point. The trend validates WHOOP's pioneering bet and signals the next competitive frontier in wearables.

1 sources

athletechnews.com

athletechnews.com

Apps & Platforms

Garmin Connect — Transparent Activity Overlays

• Update: Garmin Connect is rolling out new transparent activity overlays, a feature that T3 this week described as "copying one of Strava's best features" — and potentially improving on it. The overlay allows users to see route maps and performance data layered onto maps in a visually polished format.
• Who benefits: Garmin users who share workout screenshots or create route visualizations will gain a much-requested quality-of-life improvement. This is particularly relevant for cyclists and runners who use Garmin Connect as their primary activity log rather than Strava.

Peloton — New CEO Outlines Turnaround Plan

• Update: In a rare public interview with The New York Times published April 12, Peloton CEO Peter Stern laid out his vision for returning the fitness company to health. Stern is framing his strategy around coaching the brand back toward profitability after Peloton's market value collapsed to a fraction of its pandemic-era peak.
• Who benefits: Existing Peloton subscribers who have questioned the company's stability will be watching closely. Stern's public confidence signal is as much directed at investors and partners as it is at the consumer base. Details on product or subscription changes were not disclosed in available reporting.

Oura Ring vs. Smartwatch — 2026 Comparison Landscape

• Update: A detailed comparison piece published this week pits the Oura Ring 4 against Galaxy Watch, Garmin, and WHOOP across key metrics: sleep accuracy, battery life, workout tracking, and price. The analysis reflects a maturing consumer choice landscape where ring-form-factor wearables have become a mainstream category.
• Who benefits: Consumers evaluating their first recovery-focused wearable now have a more crowded and nuanced choice set than ever. The ring vs. watch debate is now genuinely competitive on health sensing, not just form factor preference.

1 sources

myringsizecalculator.com

myringsizecalculator.com

Health Sensing & Research

• Samsung Blood Pressure — FDA Wellness Policy Alignment: Samsung's US blood pressure launch is notable not just as a product milestone but as a regulatory one. The feature operates under the FDA's General Wellness policy, updated in January 2026, which explicitly addressed consumer wearables monitoring parameters traditionally limited to medical devices. The FDA's position — that blood pressure monitoring can qualify as a low-risk wellness feature rather than requiring a 510(k) clearance — creates a pathway that other wearable makers, including Apple, are watching carefully. As of March 2026, no new FDA clearances for mainstream consumer wearables in heart monitoring, glucose, or sleep apnea had been issued since August 2025, making Samsung's wellness-pathway approach a strategic differentiator.

• Consumer Wearables Nearing Medical-Grade Diagnostics: A broader analysis published in late March found that devices are now combining optical PPG, multi-lead ECG, accelerometry, skin impedance, and biochemical sensing in single form factors — a capability set that would have required dedicated medical hardware just a few years ago. The convergence raises important questions about validation standards: consumer accuracy levels are improving, but clinical-grade bar remains higher, and the gap between "good enough for wellness" and "good enough for diagnosis" is where regulatory and competitive tension is building.

Weekly Analysis

The dominant narrative this week is the acceleration of screenless wearables as a serious mainstream category. Garmin entering with CIRQA isn't just a product launch — it's a market validation signal that changes the stakes for WHOOP, Ultrahuman, and every other subscription-recovery-band company. Garmin's massive installed user base, distribution muscle, and reputation for sensor accuracy could compress what WHOOP has spent years building into a single competitive device cycle.

Samsung's blood pressure US launch, meanwhile, highlights a second major trend: the FDA's updated wellness guidance is creating real regulatory breathing room for health features that would have previously required years of clearance work. This could accelerate a wave of new biometric capabilities landing on mainstream wrists in the next 12–18 months. Brands that understand how to navigate the wellness-vs-medical-device boundary will have significant first-mover advantages, particularly as Apple is under pressure to respond on blood pressure.

Peloton's situation remains the cautionary counterweight to all the hardware optimism: even the best-designed fitness tech lives or dies on retention, community, and business model sustainability. That story is still being written.

What to Watch Next Week

• Garmin CIRQA official launch announcement: Multiple sources indicate the CIRQA screenless band reveal could come any day. Watch for official pricing and whether Garmin confirms a subscription-free model — that detail alone will define how disruptive this device is to the current landscape.
• Peloton Q3 earnings and strategic updates: Following CEO Peter Stern's NYT interview, Peloton's next financial disclosures and any product announcements will be closely watched by both investors and subscribers to gauge whether the turnaround narrative has substance.
• Apple Watch blood pressure response: With Samsung now offering blood pressure monitoring in the US under the FDA's wellness pathway, pressure mounts on Apple to clarify its own roadmap for the feature, which has been rumored for Apple Watch for multiple generations.